Results 31 to 40 of about 2,785 (177)
Pulmonary Leiomyomatosis in a Postmenopausal Patient After Previous Hysterectomy: A Case Report
Case Reports in Obstetrics and Gynecology, Volume 2026, Issue 1, 2026.Objective Uterine leiomyoma represents one of the most common pathologies affecting women of reproductive age, often presenting with lower abdominal pain and abnormal bleeding. Benign metastasising leiomyomatosis (BML) is a rare tumour originating from uterine leiomyomas, with the lungs being a common extrauterine location.
Ján Varga +3 more
wiley +1 more source
Obstetrics and Gynecology International, Volume 2026, Issue 1, 2026.Introduction Uterine fibroids are the most common anatomical cause of heavy menstrual bleeding. To which extent clinical practice variation is present in the treatment of fibroid‐related heavy menstrual bleeding at the hospital level remains unclear. The aim of this study was to identify and evaluate the clinical practice variation in the treatment of ...
Elisabeth R. Knorren +12 more
wiley +1 more source
Acetato de ulipristal en el tratamiento de los miomas uterinos [PDF]
, 2018 [ES] Los miomas uterinos (MU), o leiomiomas, son tumores monoclonales benignos que surgen a partir de las células del músculo liso del útero, el miometrio; contienen, además, gran cantidad de matriz extracelular con colágeno, proteoglicanos y ...
Martínez Rios, Clara Elisa
core
Role of community pharmacists in patients' self-care and self-medication [PDF]
, 2015 This review highlights the growing prominence of self-care and explores the contribution of community pharmacy. Firstly, background to self-care is discussed, followed by placing self-care in context with regard to the general public and accessing ...
Rutter, Paul
core +2 more sources
The epidemiology and pathogenesis of uterine fibroids
International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1029-1045, December 2025.Abstract Uterine fibroids, or leiomyomas, are the most common benign tumors of the female reproductive tract, ultimately affecting a majority of women worldwide, primarily during their reproductive years. While their origin appears genetic, manifesting in monoclonal tumors, diverse features and mechanisms contribute to their growth and further ...
Malcolm G. Munro +2 more
wiley +1 more source
The Concise Guide to PHARMACOLOGY 2025/26: Nuclear hormone receptors
British Journal of Pharmacology, Volume 182, Issue S1, Page S242-S258, December 2025.The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander +20 more
wiley +1 more source
Medical treatment of fibroids: FIGO best practice guidance
International Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 507-512, November 2025.Abstract Even though uterine fibroids are a widespread condition, the range of approved medical treatment options remains limited. In fact, only a few drugs are officially approved for the therapy of fibroids. In both the USA and the European Medicines Agency region, selected gonadotropin‐releasing hormone (GnRH) antagonists have been approved for this
Ivonne Diaz +2 more
wiley +1 more source
Capturing Emergency Contraceptive Pill Use: Critical Reflections on Measurement and Reporting
Studies in Family Planning, Volume 56, Issue 3, Page 470-481, September 2025.Abstract Emergency contraceptive pills (ECP) are an essential and unique postcoital method of preventing pregnancy. Trends in supply data show that sales of ECP are increasing at faster rates globally than many other contraceptives. Yet nationally representative survey data suggest that ECP use has remained relatively static overtime, suggesting ...
Joe Strong +3 more
wiley +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 8, Page 1558-1574, August 2025.After 1 year, both uterine artery embolization (UAE) and hysterectomy significantly improved health‐related quality of life (HRQOL) for patients with symptomatic adenomyosis. Neither non‐inferiority nor inferiority could be established within the predefined margins. HRQOL after 1 year was comparable in all HRQOL domains after UAE vs. hysterectomy. Both
Lisa M. Trommelen +40 more
wiley +1 more source
Neue Möglichkeit der hormonellen Notfallkontrazeption [PDF]
, 2011 Die europäische Arzneimittelbehörde EMA hat im Mai 2009 für ellaOne® (Inhaltsstoff Ulipristalacetat, UPA) die Zulassung als Notfallkontrazeptivum erteilt.
Arnet, I., Franz, E., Frey Tirri, B.
core